The higher prevalence of IPMNs compared with pancreatic cancer among FAMMM patients suggests that the high risk of pancreatic cancer may be mediated through increased IPMN formation from the p16-Leiden mutation. Here, CDKN2A is linked to pancreatic neoplasm.